Literature DB >> 6199364

Estrogen stimulates growth hormone and somatomedin-C in castrate and intact female baboons.

K C Copeland, D M Johnson, T J Kuehl, V D Castracane.   

Abstract

To evaluate the effects of physiological concentrations of estrogen on plasma concentrations of somatomedin-C (Sm-C) and GH, 16 chronic castrate female baboons were implanted either with blank Silastic capsules (n = 5) or capsules containing crystalline estradiol (E2; n = 11), which remained in place for 7 days. By day 7, serum E2 levels in treated animals rose into the physiological adult female range (mean +/- SEM, 96 +/- 9.2 pg/ml) and were greater (P less than 0.0005) than those in control animals (27.5 +/- 3.4 pg/ml). Sm-C concentrations rose significantly by day 7 in treated animals compared to those in control animals, whether assayed from unprocessed plasma (96% increase; P less than 0.01), plasma pretreated with glycine-HCl (99% increase; P less than 0.01), or plasma extracted with acid-ethanol (72% increase; P less than 0.02). GH concentrations in these animals were low and were not significantly different in E2-treated and control animals. To evaluate the effects of pharmacological doses of E2 on Sm-C and GH concentrations, six intact adult female baboons were treated with six daily injections of 1 mg E2 benzoate in oil. Serum E2 rose to a mean level of 1669 +/- 320 pg/ml on day 7. The plasma Sm-C concentration by day 7 was significantly higher than the pretreatment value whether assayed in untreated plasma (4.3-fold increase; P less than 0.01), plasma pretreated with glycine-HCl (2-fold increase; P less than 0.01), or plasma extracted with acid-ethanol (1.7-fold increase; P less than 0.01). Mean serum GH concentrations rose significantly from 3.3 ng/ml on day 0 to 23.6 ng/ml by day 7 (P less than 0.02). Evaluation of the chromatographic profile of native baboon plasma suggested a marked increase in [125I]Sm-C binding to plasma proteins after in vivo pharmacological E2 treatment; a broad peak of [125I]Sm-C binding over a size range from that of albumin to gamma-globulin was found. These results indicate that estrogen treatment of castrate or intact female baboons with both physiological and pharmacological doses results in an increase in plasma Sm-C concentrations that, at least in pharmacological doses, are mediated through an increase in GH concentrations. Although pharmacological E2 treatment results in a stimulation of plasma proteins that bind Sm-C, the effects on plasma Sm-C concentrations were found after procedures that diminish interference from circulating binding proteins. These data support the concept that estrogen may play a role in the physiological increase in plasma concentrations of Sm-C associated with normal puberty.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199364     DOI: 10.1210/jcem-58-4-698

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Bipotential effects of estrogen on growth hormone synthesis and storage in vitro.

Authors:  Gwen V Childs; Mary Iruthayanathan; Noor Akhter; Geda Unabia; Brandy Whitehead-Johnson
Journal:  Endocrinology       Date:  2004-12-23       Impact factor: 4.736

Review 2.  Estrogen mediated cross talk between the ovary and pituitary somatotrope. Pre-ovulatory support for reproductive activity.

Authors:  Gwen V Childs; Mary Iruthayanathan; Noor Akhter; Brandy W Johnson
Journal:  Mol Cell Endocrinol       Date:  2006-01-27       Impact factor: 4.102

3.  Chronic inhibition of hypothalamic-pituitary-ovarian axis and body weight gain by brain-directed delivery of estradiol-17 beta in female rats.

Authors:  D K Sarkar; S J Friedman; S S Yen; S A Frautschy
Journal:  Neuroendocrinology       Date:  1989-08       Impact factor: 4.914

4.  Both estrogen receptor α and β stimulate pituitary GH gene expression.

Authors:  Dimiter Avtanski; Horacio J Novaira; Sheng Wu; Christopher J Romero; Rhonda Kineman; Raul M Luque; Fredric Wondisford; Sally Radovick
Journal:  Mol Endocrinol       Date:  2013-01-01

5.  Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.

Authors:  P W Lu; C T Cowell; M Jimenez; J M Simpson; M Silink
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

6.  Plasma insulin-like growth factor-I, testosterone and morphological changes in the growth of captive agile gibbons ( Hylobates agilis) from birth to adolescence.

Authors:  Juri Suzuki; Akino Kato; Norihiko Maeda; Chihiro Hashimoto; Makiko Uchikoshi; Toshiaki Mizutani; Chisato Doke; Tetsuro Matsuzawa
Journal:  Primates       Date:  2003-04-25       Impact factor: 2.163

7.  Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.

Authors:  A A Massarano; C G Brook; P C Hindmarsh; P J Pringle; J D Teale; R Stanhope; M A Preece
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.